Affiliation:
1. 1 1st Internal Cardioangiological Department, St. Ann Hospital and Medical Faculty of Masaryk University, Brno, Czech Republic
Abstract
Abstract
Heart transplantation (HTX) has become an accepted treatment for selected patients with end-stage heart failure. There are two transplant centres in the Czech Republic, Prague since 1984 and Brno since 1992, in which more than 1000 heart transplantations were performed. Pharmacotherapy after heart transplantation includes the problems of immunosuppression and interactions of immunosuppressant drugs and their adverse effects. The main task for future is to find better immunosuppression with less side effects, to replace invasive bioptic examination of rejection and to find alternatives to clasical transplantation: xenotransplantation, stem cell transplantation or development of new ventricle assisst devices.
Reference21 articles.
1. 2009 International donation and transplantation activity. IRODaT preliminary data;Gelden F.;Organs, Tissues and Cells,2010
2. Specifika péče o nemocné po transplantaci srdce;Hošková L.;Cor et Vasa,2011
3. Transplantace srdce;Špinarová L.;Cor et Vasa,2008
4. Sirolimus: A novel immunosuppressive drug in heart transplantation;Kurian K.C.;Rec Patents on Cardiovasc Drug Discovery,2009
5. Cyclosporine lowering with everolimus or mycophenolate to preserve renal function in heart recipients: A randomised study;Potena L.;Transpl,2010